Lebenthal Global Advisors’s Biogen BIIB Stock Holding History

Lebenthal Global Advisors’s Portfolio BIIB Stock Details BIIB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-728	Closed	-$203K	–	166
2021 Q1	$203K	Hold	728	–	–	0.12%	128
2020 Q4	$178K	Buy	+728	New	+$188K	0.13%	106

Other funds holding BIIB

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Lebenthal Global Advisors's BIIB Position: Q2 2021 in Review

Lebenthal Global Advisors sold out of Biogen (BIIB) in Q2 2021, closing a stake of 728 shares — an estimated $203K sold.

Lebenthal Global Advisors first reported a position in BIIB in Q4 2020 and held it in 2 quarters. The position peaked at $203K in Q1 2021. 1,106 funds tracked by Wall St. Rank hold BIIB as of Q2 2021.

Lebenthal Global Advisors reported no remaining Biogen position as of Q2 2021 after selling out during the quarter.
Lebenthal Global Advisors sold 728 Biogen shares in Q2 2021, an estimated $203K.
Lebenthal Global Advisors first reported a position in Biogen in Q4 2020 and held it in 2 quarters.
Lebenthal Global Advisors's Biogen position peaked at $203K in Q1 2021.
1,106 funds tracked by Wall St. Rank held Biogen as of Q2 2021.

Based on Lebenthal Global Advisors's 13F filing for Q2 2021, filed 5 Aug 2021.